For citations:
Lopatin Yu.M., Arutyunov G.P., Ametov A.S., Ageev F.T., Antsiferov M.B., Barbarash O.L., Villevalde S.V., Vinogradova N.G., Galstyan G.R., Galyavich A.S., Gilyarevsky S.R., Glezer M.G., Zhirov I.V., Ilyin M.V., Lebedeva A.Yu., Nedogoda S.V., Salukhov V.V., Tarlovskaya E.I., Tereshchenko S.N., Fomin I.V., Khalimov Yu.Sh., Cherkashin D.V. Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial. Russian Journal of Cardiology. 2022;27(3):4945. (In Russ.) https://doi.org/10.15829/1560-4071-2022-4945
Email this article 